Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 3/20 | 0.33 |
| ▸ | MGMT | P16455 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22657962 | 1.00 | CRBN (0.33) | CRBNMGMTGAA | |
| SCHEMBL14713434 | 1.00 | CRBN (0.33) | CRBNMGMTGAA | |
| SCHEMBL29444978 | 1.00 | CRBN (0.33) | CRBNMGMTGAA | |
| SCHEMBL29521618 | 1.00 | CRBN (0.33) | CRBNMGMTGAA | |
| SCHEMBL17319197 | 1.00 | CRBN (0.33) | CRBNMGMTGAA | |
| SCHEMBL23194379 | 1.00 | CRBN (0.33) | CRBNMGMTGAA | |
| SCHEMBL14981499 | 1.00 | CRBN (0.33) | CRBNMGMTGAA | |
| SCHEMBL16329452 | 1.00 | CRBN (0.33) | CRBNMGMTGAA | |
| SCHEMBL16329449 | 0.99 | GAA (0.33) | CRBNMGMTGAA | |
| SCHEMBL26846799 | 0.93 | CRBN (0.36) | CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4299761-B1 | SURFACE-FUNCTIONALIZED OPTICAL ELEMENT | BETASENSE GMBH (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-20260133115-A1 | MASS CYTOMETRY REAGENTS AND METHODS FOR SIGNAL AMPLIFICATION | STANDARD BIOTOOLS CANADA INC. (CA) | 2026-05-14 | — | — | US | disclosed |
| US-12540893-B2 | Mass cytometry reagents and methods for signal amplification | STANDARD BIOTOOLS CANADA INC. (CA) | 2026-02-03 | — | — | US | disclosed |
| US-20260002946-A1 | SURFACE-FUNCTIONALIZED OPTICAL ELEMENT | BETASENSE GMBH (DE) | 2026-01-01 | — | — | US | disclosed |
| EP-4622678-A1 | ANTIBODY-DRUG CONJUGATE COMPRISING AN ANTI-GUCY2C ANTIBODY AS WELL AS METHODS OF PRODUCTION AND USES THEREOF | Heidelberg Pharma Research GmbH (DE) | 2025-10-01 | — | — | EP | disclosed |
| EP-3704133-B1 | REAGENTS AND METHODS FOR ELEMENTAL IMAGING MASS SPECTROMETRY OF BIOLOGICAL SAMPLES | STANDARD BIOTOOLS CANADA INC (CA) | 2025-10-01 | — | — | EP | disclosed |
| US-12422369-B2 | Immunosensor | PPB Technology Pty Ltd (AU) | 2025-09-23 | — | — | US | disclosed |
| US-12377175-B2 | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies | CORNELL UNIVERSITY (US) | 2025-08-05 | — | — | US | disclosed |
| CN-120193049-A | ZO-1 protein quantitative kit and application thereof | 上海交通大学医学院附属上海儿童医学中心 | 2025-06-24 | — | — | CN | disclosed |
| US-20250195675-A1 | NEW ANTIBODY-DRUG CONJUGATE AS WELL AS METHODS OF PRODUCTION AND USES THEREOF | HEIDELBERG PHARMA RESEARCH GMBH (DE) | 2025-06-19 | — | — | US | disclosed |
| CN-114341637-A | Immunosensor | 联邦科学工业研究组织 | 2022-04-12 | — | — | CN | disclosed |
| US-11285227-B2 | Trifunctional constructs with tunablepharmacokinetics useful in imaging and anti-tumor therapies | CORNELL UNIVERSITY (US) | 2022-03-29 | — | — | US | disclosed |
| EP-3963324-A1 | IMMUNOSENSOR | Commonwealth Scientific and Industrial Research Organisation (AU) | 2022-03-09 | — | — | EP | disclosed |
| US-11202837-B2 | Biological materials and uses thereof | ANTIKOR BIOPHARMA LIMITED (GB) | 2021-12-21 | — | — | US | disclosed |
| US-20210094975-A1 | RAPAMYCIN ANALOGS AS MTOR INHIBITORS | Revolution Medicines, Inc. | 2021-04-01 | — | — | US | disclosed |
| EP-3619216-A1 | RAPAMYCIN ANALOGS AS MTOR INHIBITORS | Revolution Medicines, Inc. (US) | 2020-03-11 | — | — | EP | disclosed |
| CN-110770243-A | Rapamycin analogs as MTOR inhibitors | 锐新医药公司 | 2020-02-07 | — | — | CN | disclosed |
| WO-2018204416-A1 | RAPAMYCIN ANALOGS AS MTOR INHIBITORS | Revolution Medicines, Inc. (US) | 2018-11-08 | — | — | WO | disclosed |
| US-20170360951-A1 | BIOLOGICAL MATERIALS AND USES THEREOF | ANTIKOR BIOPHARMA LIMITED (GB) | 2017-12-21 | — | — | US | disclosed |
| US-20170360951-A1 | BIOLOGICAL MATERIALS AND USES THEREOF | ANTIKOR BIOPHARMA LIMITED (GB) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11202837-B2 | Biological materials and uses thereof | CD47, LNPEP, TIE1 | CRBN 578/4885MGMT 499/4885GAA 500/4885 |
| US-11285227-B2 | Trifunctional constructs with tunablepharmacokinetics useful in imaging and anti-tumor therapies | MC2R, OGFR, GLS | CRBN 3588/4885MGMT 2237/4885GAA 3194/4885 |
| US-20250195675-A1 | NEW ANTIBODY-DRUG CONJUGATE AS WELL AS METHODS OF PRODUCTION AND USES THEREOF | GUCY1B2, GUCY1A2, ADCY2 | CRBN 1372/4885MGMT 757/4885GAA 573/4885 |
| US-20260002946-A1 | SURFACE-FUNCTIONALIZED OPTICAL ELEMENT | ATR, ATRIP, IGF1R | CRBN 1047/4885MGMT 751/4885GAA 4235/4885 |
| US-12377175-B2 | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies | VHL, GLS, GPER1 | CRBN 1374/4885MGMT 2456/4885GAA 3329/4885 |
| US-12540893-B2 | Mass cytometry reagents and methods for signal amplification | CD47, HLCS, SRMS | CRBN 393/4885MGMT 3638/4885GAA 4440/4885 |
| US-20260133115-A1 | MASS CYTOMETRY REAGENTS AND METHODS FOR SIGNAL AMPLIFICATION | SRMS, THOC2, TSPO | CRBN 176/4885MGMT 3905/4885GAA 4885/4885 |
| US-12422369-B2 | Immunosensor | KLK3, CD47, FCGR3B | CRBN 941/4885MGMT 718/4885GAA 978/4885 |
| US-20210094975-A1 | RAPAMYCIN ANALOGS AS MTOR INHIBITORS | MTOR, RICTOR, RPTOR | CRBN 908/4885MGMT 1624/4885GAA 981/4885 |
| US-20170360951-A1 | BIOLOGICAL MATERIALS AND USES THEREOF | CD47, LNPEP, TIE1 | CRBN 578/4885MGMT 499/4885GAA 500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.